Charlotte Guldborg Nyvold

Author

Also Known As

C G Nyvold, C NYVOLD, C Nyvold, C. G. Nyvold, C. Guldborg Nyvold, C. Nyvold, C.G. Nyvold, Charlotte Guldborg Nyvold, Charlotte G Nyvold, Charlotte G. Nyvold

144

Publications

1.5K

Citations

H-Index

Concepts

All Affiliations

Aarhus University Hospital Odense University Hospital Aarhus University Rigshospitalet University of Southern Denmark

About

Charlotte Guldborg Nyvold is an author at Aarhus University Hospital specializing in medicine, pathology, and hematology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	15	18	551
2	Natural Sciences	4	4	212
3	Engineering	1	1	41
4	Health Sciences	1	1	15
5	Public Health	1	1	22

Charlotte Guldborg Nyvold

Publications

1.1K

Citations

H-Index

Page 1

	Year	Citations
Precise quantification of minimal residual disease at day 29 allows identification of children with acute lymphoblastic leukemia and an excellent outcome Charlotte Guldborg Nyvold, Hans O. Madsen, Lars P. Ryder, Blood	2002	157
Harmonization of BCR-ABL mRNA quantification using a uniform multifunctional control plasmid in 37 international laboratories Martin C. Müller, Philipp Erben, Giuseppe Saglio, Leukemia International LaboratoriesFunctional GenomicsMolecular Biological MethodNatural SciencesGenetics	2007	107
Chimeric Antigen Receptor T Cells Targeting CD79b Show Efficacy in Lymphoma with or without Cotargeting CD19 Maria Ormhøj, Irene Scarfò, Maria L. Cabral, Clinical Cancer Research	2019	80
Relapse prediction in acute myeloid leukaemia patients in complete remission using <i>WT1</i> as a molecular marker: development of a mathematical model to predict time from molecular to clinical relapse and define optimal sampling intervals Hans Beier Ommen, Charlotte Guldborg Nyvold, Karin Brændstrup, British Journal of Haematology	2008	73
Human intestinal P‐glycoprotein activity estimated by the model substrate digoxin Ulla Lei Larsen, Hyldahl L. Olesen, Charlotte Guldborg Nyvold, Scandinavian Journal of Clinical and Laboratory Investigation	2006	59
Minimal residual core binding factor AMLs by real time quantitative PCR—Initial response to chemotherapy predicts event free survival and close monitoring of peripheral blood unravels the kinetics of relapse Jesper Stentoft, Peter Hokland, Mette Østergaard, Leukemia Research Hematological MalignancyPrognostic BiomarkersMedicineClose MonitoringImmunology	2005	59
Immunoelectron microscopy and mass spectrometry for classification of amyloid deposits Niels Abildgaard, Aleksandra Rojek, Hanne Eh Møller, Amyloid Immunocytochemical TechniqueMicroscopyAmyloid ProteinImmunologyBiological Mass Spectrometry	2019	58
h<scp>MICL</scp> and <scp>CD</scp>123 in combination with a <scp>CD</scp>45/<scp>CD</scp>34/<scp>CD</scp>117 backbone – a universal marker combination for the detection of minimal residual disease in acute myeloid leukaemia Anne Stidsholt Roug, Hanne Østergård Larsen, Line Nederby, British Journal of Haematology	2013	51
Post-induction residual leukemia in childhood acute lymphoblastic leukemia quantified by PCR correlates with in vitro prednisolone resistance Kjeld Schmiegelow, Charlotte Guldborg Nyvold, Jeanette Seyfarth, Leukemia Vitro Prednisolone ResistanceHematological MalignancyPcr CorrelatesMedicineMalignant Blood Disorder	2001	45
Molecular typing of adult acute myeloid leukaemia: significance of translocations, tandem duplications, methylation, and selective gene expression profiling Lene Olesen, Anni Aggerholm, Bodil Lind Andersen, British Journal of Haematology EngineeringMixed-phenotype Acute LeukemiaGeneticsTandem DuplicationsImmunology	2005	41

Page 1